Theatre 8: Brain Stimulation

Below is the 2019 agenda. The 2020 timetable will be released closer to the event.

Tuesday 26th March

Wednesday 27th March

speaker

11.00 - 11.30

Dr Martine Stoffels

r-TMS in neuropsychiatric conditions.

Does r-TMS benefit people who have neuropsychiatric disorders? This seminar will provide you with additional insights on what r-TMS treatment involves, conditions which can be treated, and the outcomes of treatment.

speaker

11.45 - 12.15

Richard Welch and Helen Adams

What could an electrostimulation Suit do for my patient?

Discover how the Mollii Suit’s personalised electrostimulation makes an instant and on-going response for patients with muscle tone and movement disorders. Hear how to select suitable candidates for an individual assessment and how it enhances existing therapy.

speaker

12.30 - 13.00

Aziz Kaddan

Home EEG-based Therapy

Learn how EEG-based biofeedback, or neurofeedback, can be used as a home therapy for various neurological conditions and to improve cognitive functioning. The convenience and accessibility of home training using a mobile phone or tablet and a wireless EEG headset has many implications for neurofeedback therapy.

speaker

13.15 - 13.45

Khashayar Pazooki

QEEG /ERP & psychometry into an individualized & personalized medicinal treatment Model of psychiatric disorders

This seminar is giving you an insight of an innovative model combining different instruments, such as the quantitative electroencephalography (qEEG), ERP-Measurements and other psychometric questionnaires into an individualized and personalized form of differential diagnostic in medicinal treatment of psychological and psychiatric diseases.

speaker

14.00 - 14.30

Dr Camilla Nord

Neurobiological predictors of response to tDCS-enhanced psychological therapy in depression

We conducted a randomised controlled trial to test whether transcranial direct current stimulation (tDCS) would enhance clinical response to cognitive behavioural therapy in depression. We showed a 20% improvement of real over sham tDCS, which was not significant. However, we found that baseline dorsolateral prefrontal cortex activation was specifically associated with response to tDCS. This could potentially have use as a “biomarker” identifying patients who might respond to tDCS.

speaker

14.45 - 15.15

Prof Michael Banissy

Changing social processing with non-invasive brain stimulation

Recently there has been considerable interest in using non-invasive brain stimulation to aid performance in typical and atypical groups. One example is the field of social processing, where non-invasive brain stimulation has been suggested to support the perception of one’s own affective states (e.g. mood) and those others (e.g.emotion perception). In this seminar we will explore and discuss the implications of evidence related to this claim.

speaker

15.30 - 16.00

Marta Castellano

Brain monitoring technologies in the clinical and wellness domain

Cost-effective direct measures of brain activity, in combination with advanced signal processing and machine learning techniques, provide an ideal tool for the quantification of treatment results reported in a format tailored to each user. Can non-invasive brain monitoring technologies one day be used for to measure brain health?